Keyphrases
I-Corps
100%
Tolerability
100%
Stimulant Medication
100%
Abuse Liability
42%
Addiction
28%
Opioids
28%
Commercial Potential
14%
Neurological Conditions
14%
Impact Review
14%
Analgesic Effect
14%
Treatment Outcome
14%
Amphetamine
14%
Stimulants
14%
Therapeutic Effect
14%
Attention Deficit Hyperactivity Disorder
14%
Binge Eating
14%
Stimulant Drugs
14%
Platform Technology
14%
Safety Profile
14%
Therapeutic Efficacy
14%
Review Criteria
14%
Drug Enforcement Administration
14%
Psychiatric Conditions
14%
Proof of Concept Study
14%
Co-formulated
14%
Treatment Adherence
14%
Neuroscience
14%
Pharmacology, Toxicology and Pharmaceutical Science
Tolerability
100%
Adjuvant
66%
Combination Therapy
33%
Binge Eating Disorder
33%
Dexamphetamine
33%
Stimulant
33%
Attention Deficit Disorder
33%
Analgesic Agent
33%
Therapeutic Effect
33%
Medicine and Dentistry
Analeptic
100%
Adjuvant
22%
Addictive Behavior
22%
Therapy Effect
11%
Combination Therapy
11%
Patient Compliance
11%
Analgesic Activity
11%
Dextroamphetamine
11%
Attention Deficit Disorder
11%
Night Eating Syndrome
11%